İleri Evre High Grade Lenfoma Tedavisi / Treatment of Advanced-Stage High-Grade B-Cell Lymphoma

Treatment of Advanced High-Grade B-Cell Lymphoma 🧬 Systemic treatments are used in the treatment of advanced High-Grade B-Cell Lymphoma. These treatments are called chemoimmunotherapy. That is, chemotherapy + targeted therapy are given together. 💊 Main protocols: 1️⃣ R-CHOP • Rituximab + chemotherapies + prednisolone • Usually administered daily and every 21 days. 2️⃣ Dose-Adjusted R-EPOCH • A more intensive protocol than R-CHOP. • Usually administered in the hospital and as a continuous infusion. 3️⃣ R-Pola-CHP • Rituximab + Polatuzumab vedotin + chemotherapies • A modern option targeting CD79b. 📊 An interim evaluation is usually done after 3-4 cycles. If the response is good, treatment is usually completed in 6 cycles. ⚠️ Liver, kidney, and heart functions, infections, and central nervous system risks should be closely monitored during treatment. 📌 Summary: Treatment is intensive, but the goal is complete response and cure. ________ Treatment of Advanced-Stage High-Grade B-Cell Lymphoma 🧬 Advanced-stage high-grade B-cell lymphoma is treated with systemic therapy called chemo-immunotherapy. This means chemotherapy combined with targeted immunotherapy. 💊 Main regimens: 1️⃣ R-CHOP • Rituximab + chemotherapy + prednisone • Usually given outpatiently every 21 days. 2️⃣ Dose-Adjusted R-EPOCH • More intensive than R-CHOP • Usually given inpatient as a continuous infusion. 3️⃣ R-Pola-CHP • Rituximab + Polatuzumab vedotin + chemotherapy • A modern CD79b-targeted option. 📊 Interim assessment is usually done after 3–4 cycles. If response is good, treatment is commonly completed to 6 cycles. ⚠️ Liver, kidney, heart function, infections, and central nervous system risk must be closely monitored. 📌 Summary: Treatment is intensive, but the goal is complete response and cure. #HighGradeLymphoma #BCellLymphoma #LymphomaTreatment #RCHOP #REPOCH #Polatuzumab #Chemoimmunotherapy #HighGradeLymphoma #BCellLymphoma #LymphomaTreatment #RCHOP #REPOCH #Polatuzumab #Chemoimmunotherapy